| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |